Juva Life Announces Completion of Stockton, California, Cannabis Cultivation Facility, Doubling Harvest Capacity
21 mars 2022 04h00 HE
|
Juva Life Inc.
VANCOUVER, British Columbia, March 21, 2022 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life science company with...
Juva Life Launches Journal App, Offering Personal Health and Wellness Tracking for Cannabis Patients
02 mars 2022 04h00 HE
|
Juva Life Inc.
VANCOUVER, British Columbia, March 02, 2022 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life science company with...
Juva Life Announces Filing of Patent on JUVA-041 – Small Molecule Isolated from the Cannabis Plant
02 févr. 2022 04h00 HE
|
Juva Life Inc.
VANCOUVER, British Columbia, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life science company with...
Juva Life Validates Discovery Strategy and Technology Platform, Leading to Discovery of Second Novel Drug Candidate, JUVA-041 Nominated for Pre-Clinical Development
24 janv. 2022 04h00 HE
|
Juva Life Inc.
VANCOUVER, British Columbia, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life science company with...
Juva Life Advances JUVA-019 into Preclinical Development for Inflammatory Disease
06 janv. 2022 04h00 HE
|
Juva Life Inc.
VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life sciences portfolio company...
Juva Life Expands WIRB-Approved Cannabis Patient Registry Study
14 déc. 2021 04h00 HE
|
Juva Life Inc.
REDWOOD CITY, Calif., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life sciences portfolio company with...
Juva Life Reports 322% Increase in Revenue in 2021 Third Quarter Financial and Operational Results Filing
02 déc. 2021 04h00 HE
|
Juva Life Inc.
VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life sciences portfolio company...
Juva Life Launches Preclinical Comparative Study to Evaluate Anti-Inflammatory Properties of Candidate JUVA-019 in Conjunction With Other Well-Known Cannabinoids
30 nov. 2021 04h00 HE
|
Juva Life Inc.
VANCOUVER, British Columbia, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life sciences portfolio company...
Juva Life Identifies Second Molecular Compound Found in Cannabis With Significant Anti-Inflammatory Therapeutic Properties Coined JUVA-041
15 nov. 2021 04h30 HE
|
Juva Life Inc.
VANCOUVER, British Columbia, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life sciences portfolio company...
Juva Life Files Patent on Family of Non-Cannabinoid Small Molecules Targeting Consumer and Pharma Inflammatory Indications
14 oct. 2021 00h05 HE
|
Juva Life Inc.
VANCOUVER, British Columbia, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a California based life sciences...